Skip to main content

Table 6 Comparison of patient characteristics based on success rates within the RM group

From: Feasibility of hand grip tests during and after hospitalization in geriatric patients: an observational study

 

Complete, N = 94

High, N = 54

Moderate, N = 9

Low, N = 12

p-value

Sex (female)

n (%)

45 (48%)

30 (56%)

4 (44%)

7 (58%)

0.78

Age (years)

Median [IQR]

82.7 [75.7, 88.6]

81.7 [78.9, 87.0]

81.1 [76.3, 90.0]

79.0 [72.9, 85.2]

0.65

CFS

     

0.36

 Fit (CFS 1-3)

n (%)

14 (15%)

5 (9.3%)

0 (0%)

0 (0%)

 

 Mild to moderate (CFS 4-6)

n (%)

38 (40%)

29 (54%)

5 (56%)

4 (33%)

 

 Severe (CFS 7-9)

n (%)

42 (45%)

20 (37%)

4 (44%)

8 (67%)

 

Frailty Index

Median [IQR]

0.3 [0.3, 0.4]

0.4 [0.2, 0.4]

0.4 [0.3, 0.5]

0.3 [0.3, 0.4]

0.53

Multimorbidity

Median [IQR]

4.0 [3.0, 6.0]

4.0 [3.0, 6.0]

5.0 [4.0, 7.0]

4.0 [3.0, 5.0]

0.25

Nr. of medications prior to admission

Median [IQR]

10.0 [7.0, 13.0]

11.5 [6.0, 14.0]

15.0 [14.0, 17.0]

12.5 [9.5, 16.0]

0.02

EuroQol 5D

Median [IQR]

0.4 [0.2, 0.6]

0.4 [0.1, 0.6]

0.1 [0.1, 0.4]

0.6 [0.3, 0.7]

0.23

Psychological well-being

Median [IQR]

76.0 [60.0, 88.0]

76.0 [56.0, 84.0]

68.0 [52.0, 84.0]

80.0 [57.0, 96.0]

0.54

(i)ADL before admission

Median [IQR]

24.0 [18.0, 31.0]

24.0 [18.0, 30.0]

27.0 [21.0, 35.0]

24.0 [23.0, 26.0]

0.78

(i)ADL at admission

Median [IQR]

37.0 [32.0, 39.0]

37.0 [33.3, 39.0]

37.0 [32.0, 38.0]

32.5 [27.8, 37.8]

0.51

Treatment focus

     

0.80

 Curative

n (%)

21 (22%)

7 (13%)

1 (11%)

3 (25%)

 

 Recovery-oriented care

n (%)

68 (72%)

43 (83%)

8 (89%)

9 (75%)

 

 Symptom-oriented care

n (%)

5 (5.3%)

2 (3.8%)

0 (0%)

0 (0%)

 

Length of stay (days)

Median [IQR]

8.0 [5.0, 11.0]

10.5 [7.3, 15.8]

12.0 [4.0, 14.0]

9.0 [6.5, 11.3]

0.04

Deceased during admission

n (%)

2 (2.2%)

0 (0%)

1 (11%)

2 (17%)

0.01

 

Men, N = 49

Women, N = 45

Men, N = 24

Women, N = 30

Men, N = 5

Women, N = 4

Men, N = 5

Women, N = 7

 

GSmax at baseline (kPa)

Median [IQR]

50 [39, 61]

36 [26, 48]

51 [39, 59]

34 [26, 44]

50 [45, 54]

33 [30, 38]

35 [23, 38]

27 [20, 29]

M: 0.16

W: 0.30

FR at baseline (s)

Median [IQR]

24 [18, 32]

22 [15, 37]

24 [18, 27]

18 [12, 26]

13 [12, 14]

11 [11, 11]

NA

NA

M: 0.12

W: 0.08

GW at baseline (kPa*s)

Median [IQR]

855 [614, 1172]

567 [330, 1169]

963 [618, 1072]

419 [310, 753]

731 [647, 815]

289 [289, 289]

NA

NA

M: 0.72

W: 0.27

  1. Complete group: patients having 100% successful tests. High group: patients having 50%-99 successful tests. Moderate group: patients having 25%-49% successful tests. Low group: patients having 25% or less successful tests (no participants in this group)
  2. CFS (Clinical Frailty Scale): 1-9, lower is better. Frailty index: 0-1, lower is better. Multimorbidity: 0-17, lower is better. EuroQol 5D: -0.4-1, higher is better. (i)ADL: (instrumental) Activities of Daily Living, 5-40, higher scores indicate more dependency. Psychological wellbeing: 0-100, higher is better. GSmax: maximal Grip Strength, higher is better. FR: Fatigue resistance, higher is better. GW: Grip Work, higher is better